Abstract

Although mTOR signaling is known as a broad regulator of cell growth and proliferation, in neurons it regulates synaptic transmission, which is thought to be a major mechanism through which altered mTOR signaling leads to neurological disease. Although previous studies have delineated postsynaptic roles for mTOR, whether it regulates presynaptic function is largely unknown. Moreover, the mTOR kinase operates in two complexes, mTORC1 and mTORC2, suggesting that mTOR's role in synaptic transmission may be complex-specific. To better understand their roles in synaptic transmission, we genetically inactivated mTORC1 or mTORC2 in cultured mouse glutamatergic hippocampal neurons. Inactivation of either complex reduced neuron growth and evoked EPSCs (eEPSCs), however, the effects of mTORC1 on eEPSCs were postsynaptic and the effects of mTORC2 were presynaptic. Despite postsynaptic inhibition of evoked release, mTORC1 inactivation enhanced spontaneous vesicle fusion and replenishment, suggesting that mTORC1 and mTORC2 differentially modulate postsynaptic responsiveness and presynaptic release to optimize glutamatergic synaptic transmission.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Matthew P McCabe

    Neurological Sciences, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Erin R Cullen

    Neurological Sciences, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Caitlynn M Barrows

    Neurological Sciences, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4696-9354
  4. Amy N Shore

    Neurological Sciences, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Katherine I Tooke

    Neurological Sciences, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Kathryn A Laprade

    Neurological Sciences, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. James M Stafford

    Neurological Sciences, University of Vermont, Burlington, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Matthew C Weston

    Neurological Sciences, University of Vermont, Burlington, United States
    For correspondence
    mcweston@uvm.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5558-7070

Funding

National Institute of Neurological Disorders and Stroke (R00NS087095)

  • Matthew C Weston

National Institute of Neurological Disorders and Stroke (R01NS110945)

  • Matthew C Weston

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols of the University of Vermont. The protocol was approved by the University of Vermont's Research Protections Office (Protocol Number: 16-001). All animals were killed under isofluorane anesthesia, and every effort was made to minimize suffering.

Copyright

© 2020, McCabe et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,411
    views
  • 694
    downloads
  • 55
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Matthew P McCabe
  2. Erin R Cullen
  3. Caitlynn M Barrows
  4. Amy N Shore
  5. Katherine I Tooke
  6. Kathryn A Laprade
  7. James M Stafford
  8. Matthew C Weston
(2020)
Genetic inactivation of mTORC1 or mTORC2 in neurons reveals distinct functions in glutamatergic synaptic transmission
eLife 9:e51440.
https://doi.org/10.7554/eLife.51440

Share this article

https://doi.org/10.7554/eLife.51440